Pacific Northwest


Liver-Related Information

In Your Area

Simply Speaking HBV: An Expert Educators CME Lecture Series (Bellevue)

The American Liver Foundation Pacific Northwest Division invites you to join us for "Clinical Perspectives in the Management of Chronic HBV Infection: A Case-Based Approach"

December 11th, 2012 - December 11th, 2012 (6:00pm - 8:00pm)

Contact: Regina Stacy (Email)
Phone: (813) 891-6999 | Register | More Information

Hosted by American Liver Foundation
Ruth's Chris Steakhouse - Directions
565 Bellevue Square
Bellevue, WA 98004

Activity Overview:
This course is designed for physicians treating hepatitis B patients. Physician assistants, nurse practitioners, registered nurses, and pharmacists are also welcome to participate.

Guest Educator:
Aijaz Ahmed, MD
Associate Professor of Medicine
Stanford University School of Medicine
Stanford, CA

Learning Objectives (CME/CE):
Upon completion of this activity, the participant intends to incorporate the following objectives into their practice of medicine:

  • Screen and test for hepatitis B virus (HBV) infection in my patients at high risk for HBV infection according to the recommendations from the Centers for Disease Control and Prevention.
  • Diagnose HBV infection using the tests recommended by the American Association for the Study of Liver Diseases (AASLD).
  • Counsel my patients with chronic HBV on the impact of current antiviral therapies on the rate of HBsAg seroconversion, disease progression, and the development of hepatocellular carcinoma.
  • Appropriately select anti-HBV therapy in my HBV-infected patients who are candidates for therapy according to the AASLD recommendations.

Learning Objectives (CPE):
Upon completion of this activity, the pharmacist should be able to:

  • Discuss the screening and testing recommendations for hepatitis B virus (HBV) infection according to the recommendations from the Centers for Disease Control and Prevention.
  • Discuss tests used to diagnose HBV infection as recommended by the American Association for the Study of Liver Diseases (AASLD).
  • Counsel my patients with chronic HBV on the impact of current antiviral therapies on the rate of HBsAg seroconversion, disease progression, and the development of hepatocellular carcinoma.
  • Discuss anti-HBV therapy in my HBV-infected patients who are candidates for therapy according to the AASLD recommendations.

To Register:
To register for this event, please visit www.simplyspeakinghbv.com and use the event code 23200222 (an invitation code does not apply). If you have any questions, please contact Regina Stacy with Practice Point Communications at (813) 891-6999, rstacy@practicepointinc.com or Jeffrey Petrovic with the American Liver Foundation in Seattle at (212) 668-1000 x2801, jpetrovic@liverfoundation.org.

Page updated: October 29th, 2012